XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Product sales $ 1,852,000 $ 823,000 $ 3,278,000 $ 1,498,000
Other revenue 82,000 10,000 198,000 24,000
Total revenues 1,934,000 833,000 3,476,000 1,522,000
Cost of revenues:        
Products and services 1,247,000 565,000 2,184,000 971,000
Product line exit expense 747,000 0 747,000 0
Total cost of revenues 1,994,000 565,000 2,931,000 971,000
Gross profit (loss) (60,000) 268,000 545,000 551,000
Operating expenses:        
Selling, general and administrative 6,579,000 2,538,000 11,557,000 4,678,000
Research and development 1,162,000 577,000 2,227,000 1,111,000
Total operating expenses 7,741,000 3,115,000 13,784,000 5,789,000
Loss from operations (7,801,000) (2,847,000) (13,239,000) (5,238,000)
Other income (expense):        
Investment income 8,000 31,000 10,000 76,000
Other (6,000) 0 1,000 0
Other income (expense) 2,000 31,000 11,000 76,000
Net loss $ (7,799,000) $ (2,816,000) $ (13,228,000) $ (5,162,000)
Net loss per basic and diluted common share $ (0.20) $ (0.09) $ (0.35) $ (0.17)
Weighted average common shares used to compute net loss per basic and diluted common share 38,162,526 31,241,470 37,938,873 30,749,532
Comprehensive loss:        
Net loss $ (7,799,000) $ (2,816,000) $ (13,228,000) $ (5,162,000)
Net unrealized loss on short-term investments (4,000) 0 (2,000) 0
Comprehensive loss $ (7,803,000) $ (2,816,000) $ (13,230,000) $ (5,162,000)